Table 3.
Association between Vitamin D level and metabolic syndrome
| Adjusted OR (95% CI) | ||||||
|---|---|---|---|---|---|---|
| Alla | Insufficiency vs. normal | P-value | Deficiency vs. normal | P-value | ||
| Metabolic syndrome | 1.673 (1.220–2.295) | 0.001 | 1.770 (1.145–2.736) | 0.010 | ||
| NAFLDb | ||||||
| Metabolic syndrome | 1.633 (1.125–2.369) | 0.010 | 1.607 (0.962–2.685) | 0.070 | ||
| Alla | Q1 vs. Q4 | P-value | Q2 vs. Q4 | P-value | Q3 vs. Q4 | P-value |
| Metabolic syndrome | 2.473 (1.580–3.871) | < 0.001 | 1.896 (1.243–2.893) | 0.003 | 1.881 (1.243–2.846) | < 0.001 |
| NAFLDb | ||||||
| Metabolic syndrome | 2.358 (1.386–4.013) | 0.002 | 1.858 (1.113–3.103) | 0.018 | 1.972 (1.202–3.235) | 0.007 |
OR odds ratio, CI = 95% confidence interval,
Vitamin D levels: normal (> 30 ng/ml), insufficiency (20–30 ng/ml), deficiency (< 20 ng/ml).
Vitamin D quartile: Q1 (< 22.41 ng/ml), Q2 (22.41–28.41 ng/ml), Q3 (28.41–35.38 ng/ml), Q4 (> 35.38 ng/ml).
aadjusted for confounding factors: age, gender, BMI and NAFLD status
badjusted for confounding factors: age, gender and BMI